Necrotizing enterocolitis (NEC) remains a common emergency that carries high morbidity and mortality for extremely low birth weight infants. To date there have been no multicenter randomized controlled trials to evaluate different feeding strategies and NEC. Clinicians must weigh their experience against small amounts of data in deciding the best way to feed their patients. Currently published feeding protocols and evidence for the same will be reviewed. Also reviewed is the evidence for use of human milk, initiation and advancement of feedings, and the use of probiotics.
Introduction
Despite concerns that enteral feedings are associated with the development of necrotizing enterocolitis (NEC) in extremely low birth weight (ELBW) infants, to date there have been no multicenter randomized controlled trials to evaluate different feeding strategies and NEC. The one risk factor for development of NEC that continues to hold the test of time is prematurity. Issues such as when to initiate feeds and how fast to advance feeds remain controversial. Furthermore, the practice of feeding with umbilical artery catheters in place and during patent ductus arteriosus (PDA) treatment remains quite variable from center to center. And although feeding human milk does seem to afford some protection from NEC, the amount required for the protective effect and the influence of additives remains to be defined. So how does the practicing neonatologist incorporate into daily care the evidence, or lack thereof, for feeding strategies in the ELBW infant?
Experience-based medicine Given the paucity of evidence for how to feed the ELBW infant, many clinicians base their practices on their own historical experiences. One group recently published its 20-year experience on feeding the ELBW infant, which examined the prevalence of bowel perforation and NEC in a population of preterm infants not exposed to indomethacin and fed on a strict feeding protocol. 1 The cohort was 1239 infants with birth weight from 501 to 1500 g admitted to a level 3 unit from 1986 to 2005. Outcome data were compared to the Vermont Oxford Network (VON) data from the previous 3 years.
Details of their feeding protocol can be found in their paper. Infants were stratified according to birth weight and main features included a delay in onset of feeding as long as 10 days for infants with birth weight p750 g, slow advancement of continuous drip feeds once initiated and use of formula or breast milk with caloric density of 10 or 20 kcal per oz. Relevant unit practices include medical treatment of symptomatic PDA with use of diuretics, fluid restriction and afterload reduction using captopril. Indomethacin was not used, and they reported only a 3.6% ductal ligation rate from 2002 to 2005 compared to a 7.6% incidence in VON from 2002 to 2004. Glycerin suppositories were also given to ensure a regular stooling pattern.
Results comparing the 20-year experience to 3-year VON experience from 2002 to 2004 showed only a 0.4% incidence of NEC in the group of infants who underwent the strict feeding protocol and did not receive indomethacin nor early dexamethasone vs a 5.9% incidence in VON. Over the 20 years, 81 infants were not fed according to protocol and/or were exposed to indomethacin and/or early dexamethasone. In this subgroup, the incidence of NEC was 6%. As the authors point out, what remains to be determined is if the feeding protocol, lack of exposure to indomethacin, lack of exposure to early dexamethasone treatment or some combination of the above led to the low incidence of NEC. However, no data are presented on the use of central intravenous lines, incidence of infections, hepatic dysfunction and so on.
Other groups have also reported a reduced incidence of NEC with introduction of feeding protocols into their general practice. At the time of publication, one group in the Netherlands had seen three consecutive years without a case of NEC in infants <2000 g after introduction of a 'cautious feeding regimen.' 2 In infants 1250 to 2500 g birth weight and <35 weeks gestational age, the incidence of NEC was reduced from 4.8 to 1.1% with the introduction of standardized feeding schedules. 3 Each published feeding protocol differs from one another, and the broader application of such practices remains to be studied in a prospective, randomized fashion.
Evidence-based medicine for the use of human milk The use of human milk for term babies is widely accepted as the best type of nutrition. It has now become recognized as optimal food for the preterm infant as well, and for the ELBW infant, prevention of NEC seems to be an important benefit. In 1990, Lucas and Cole 4 showed NEC was 6 times more likely in infants <1,850 g exclusively formula fed than those exclusively fed human milk (from mother or donor); NEC was 3.5 times higher in those fed formula only vs those fed combined formula and human milk. Schanler et al. 5 showed infants fed X50 ml kg À1 per day of fortified mother's milk were statistically less likely to develop NEC than those fed only premature infant formula (1.6 vs 13%). The association of use of mother's milk and decreased incidence of NEC has recently been confirmed. In 2007, Sisk et al. 6 published a sixfold decrease in the incidence of NEC when infants with birth weight 700 to 1500 g received X50% of enteral feeds as human milk as compared to those who received <50% human milk in the first 14 days of life. The three studies are quite similar in showing the protective effects of mother's milk even with use of human milk fortifiers.
The study by Lucas and Cole 4 suggested that donor breast milk was protective of NEC similar to mother's own milk. However, meta-analyses of data published since this study have failed to show a high quality of evidence to support the use of donor breast milk over preterm formula; the protective effect for NEC is not conclusive, and infants receiving donor milk seem to have poorer growth compared to those receiving preterm formula. 7, 8 Authors estimate a proper blinded, randomized controlled trial to confirm the protective effect of donor milk for NEC would take an approximately 900 patients from approximately 30 centers with access to donor breast milk; the estimated number to treat is one case of NEC prevented for every 20 infants who receive donor breast milk. 7 Schanler et al. 9 did not show a protective effect for NEC when use of donor breast milk was compared to use of premature infant formula for patients who had an insufficient supply of mother's own milk; 21% of infants receiving donor milk had to be changed to premature infant formula due to poor weight gain. The use of mother's own milk seems protective and appropriate for the prevention of NEC, whereas use of donor milk still lacks strong supportive evidence and must be weighed against other issues such as safety and cost.
Evidence-based medicine for initiation and advancement of feedings There is wide variation among clinicians in what constitutes early vs delayed enteral feedings. In the most recent Cochrane Review, early feeding was defined as initiation by 4 days of age, and the review failed to gather enough data to make any firm conclusion on when enteral feedings should be initiated. 10 A study from Norway showed early feedings with human milk reduced the risk of late onset sepsis for infants <1000 g. In this cohort, 98% of infants had feeds initiated by the third day of life, and 89% had achieved full enteral feeds within the third week of life. Participating centers had a common policy of using mother's milk or banked donor milk; however, the use of donor milk was only 6% once full enteral feeds had been achieved. The relative risk for sepsis if feeds had not been achieved by 14 days was 3.7 (95% confidence interval: 2 to 6.9); late onset sepsis was defined as positive blood culture in conjunction with clinical symptoms consistent with systemic infection occurring after day 6 of life. The rate of NEC was only 2.2%.
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In respect to slow vs rapid advancement of feedings, the most recent Cochrane Review on trophic feedings failed to gather enough data to make recommendations on feeding practice.
12 A study by Berseth et al. 13 was terminated early due to concerns for higher rates of NEC in the group of infants receiving advancing feedings of 20 ml kg À1 per day every day for the first 10 study days as opposed to the group that received 20 ml kg À1 per day without advancement for the first 10 study days. Infants who were not advanced rapidly established full enteral feedings later but had the same maturation of intestinal motor patterns, the same rate of late onset sepsis and the same occurrence of feeding intolerance as the rapidly advanced group. Day of entry into the study, however, was an average of 9 to 10 days of life for both groups and only 18 to 24% of infants received breast milk. 13 At the time of feeding initiation, clinicians must also choose between gastric feeds in continuous or bolus schedules. Bolus tubefeeding method has been shown to have less feeding intolerance and greater rate of weight gain than continuous feedings but did not show a difference in time to achieve full oral feedings or time to discharge.
14 Transpyloric feeds are also used by some, but no data exists to support their use in the ELBW infant in regards to initiation of feeds and safety.
Evidence-based medicine for use of probiotics It is speculated that the bacterial flora, which colonizes a premature infant's gastrointestinal (GI) tract, may predispose the infant to NEC. Premature infants often have delays in initiation of feedings, which result in delays in colonization. As they are colonized, they are exposed to more virulent organisms found in the neonatal intensive care unit environment as well as exposed to broad-spectrum antibiotics, which can suppress more common bacteria and allow more invasive ones to predominate. Furthermore, the lack of contact with normal maternal flora and limited use of human milk can predispose the premature infant's GI tract to colonization with organisms other than those considered 'normal'. It is hypothesized that these factors, along with an immature intestinal mucosa and exposure to invasive procedures, create an environment for NEC. Researchers have hypothesized that oral probiotics can decrease the incidence of NEC by reducing enteric pathogens, improving gut structure and function and enhancing the gut mucosal barrier. These benefits would also facilitate establishment of enteral nutrition and decrease the rate of nosocomial infections and sepsis. However, case reports have been published about infants who have developed nosocomial infections from agents used in probiotics including sepsis from Lactobacillus species 15 and fungemia from Saccharomyces species. 16 Recently a meta-analysis on the use of probiotics to prevent NEC was published in Lancet. Deshpande et al. 17 narrowed their search to seven relevant studies on the use of probiotics in infants <33 weeks gestational age at birth. They found a reduced risk for NEC in the probiotic group vs controls. They did not find a difference in the rate of blood culture-positive sepsis between the two groups. Pooled data from five of the trials showed a reduced risk of death from all causes in the probiotic group compared to controls, and data from three trials showed a reduction in the time to reach full feeds for the probiotic group when compared to controls. However, the dose, duration and type of probiotic agents to use could not be determined, and the authors also recommend large trials to determine short and long-term safety issues. 17 
Conclusion
A variety of protocols exist for feeding the ELBW infant. Individual clinicians have personal preferences on when to initiate and advance feeds; however, consistency in practice within a unit can help lower rates of NEC. To date use of human milk from the patient's own mother affords the most consistent protection from NEC. Probiotics may have a future role for prevention of NEC but large trials are needed to determine treatment regimens and safety. Although NEC continues to be a leading cause of morbidity and mortality for ELBW babies, treatment remains supportive with no clear path for prevention. Feeding our tiny patients continues to remain a challenge with many different facets we have yet to put together.
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